23-Valent Pneumococcal Polysaccharide Vaccine Market - Forecast(2024 - 2030)

Report Code: HCR 32857 Report Format: PDF + Excel

$ 4250 Single User License ?
$ 5900 Corporate User License ?

Table of Contents

1. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Overview
        1.1 Definitions and Scope
2. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. 23-Valent Pneumococcal Polysaccharide Vaccine Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. 23-Valent Pneumococcal Polysaccharide Vaccine Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. 23-Valent Pneumococcal Polysaccharide Vaccine Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. 23-Valent Pneumococcal Polysaccharide Vaccine Market - By Age-Group (Market Size -$Million / $Billion)
        8.1 Child
        8.2 Adult
        8.3 Geriatrics
9. 23-Valent Pneumococcal Polysaccharide Vaccine Market - By Dose Type (Market Size -$Million / $Billion)
        9.1 Single Dose Vial
        9.2 Pre-Filled Syringe
10. 23-Valent Pneumococcal Polysaccharide Vaccine - By Application (Market Size -$Million / $Billion)
        10.1 Segment type Size and Market Share Analysis
        10.2 Application Revenue and Trends by type of Application
        10.3 Application Segment Analysis by Type
11. 23-Valent Pneumococcal Polysaccharide Vaccine- By Geography (Market Size -$Million / $Billion)
        11.1 23-Valent Pneumococcal Polysaccharide Vaccine Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 23-Valent Pneumococcal Polysaccharide Vaccine- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 23-Valent Pneumococcal Polysaccharide Vaccine- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 23-Valent Pneumococcal Polysaccharide Vaccine - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong kong
                  11.8.5.9 Rest of APAC
        11.9 23-Valent Pneumococcal Polysaccharide Vaccine - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Key Company List by Country Premium
15. 23-Valent Pneumococcal Polysaccharide Vaccine Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 Astrazeneca
        15.3 Baxter International Inc
        15.4 Beijing Minhai Biotechnology
        15.5 Biogen Inc
        15.6 Eli Lilly And Company
        15.7 Glaxosmithkline Plc
        15.8 Merck Co
        15.9 Pfizer Inc
        15.10 Sanofi S A
        15.11 Serum Institute Of India
        15.12 Company 12
        15.13 Company 13 & More

*Financials would be provided on a best efforts basis for private companies

16. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type Market 2023-2030 ($M)
1.1 Single Dose Vial Market 2023-2030 ($M) - Global Industry Research
1.2 Pre-Filled Syringe Market 2023-2030 ($M) - Global Industry Research
2.Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-Group Market 2023-2030 ($M)
2.1 Child Market 2023-2030 ($M) - Global Industry Research
2.2 Adult Market 2023-2030 ($M) - Global Industry Research
2.3 Geriatrics Market 2023-2030 ($M) - Global Industry Research
3.Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type Market 2023-2030 (Volume/Units)
3.1 Single Dose Vial Market 2023-2030 (Volume/Units) - Global Industry Research
3.2 Pre-Filled Syringe Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-Group Market 2023-2030 (Volume/Units)
4.1 Child Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Adult Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Geriatrics Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type Market 2023-2030 ($M)
5.1 Single Dose Vial Market 2023-2030 ($M) - Regional Industry Research
5.2 Pre-Filled Syringe Market 2023-2030 ($M) - Regional Industry Research
6.North America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-Group Market 2023-2030 ($M)
6.1 Child Market 2023-2030 ($M) - Regional Industry Research
6.2 Adult Market 2023-2030 ($M) - Regional Industry Research
6.3 Geriatrics Market 2023-2030 ($M) - Regional Industry Research
7.South America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type Market 2023-2030 ($M)
7.1 Single Dose Vial Market 2023-2030 ($M) - Regional Industry Research
7.2 Pre-Filled Syringe Market 2023-2030 ($M) - Regional Industry Research
8.South America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-Group Market 2023-2030 ($M)
8.1 Child Market 2023-2030 ($M) - Regional Industry Research
8.2 Adult Market 2023-2030 ($M) - Regional Industry Research
8.3 Geriatrics Market 2023-2030 ($M) - Regional Industry Research
9.Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type Market 2023-2030 ($M)
9.1 Single Dose Vial Market 2023-2030 ($M) - Regional Industry Research
9.2 Pre-Filled Syringe Market 2023-2030 ($M) - Regional Industry Research
10.Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-Group Market 2023-2030 ($M)
10.1 Child Market 2023-2030 ($M) - Regional Industry Research
10.2 Adult Market 2023-2030 ($M) - Regional Industry Research
10.3 Geriatrics Market 2023-2030 ($M) - Regional Industry Research
11.APAC 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type Market 2023-2030 ($M)
11.1 Single Dose Vial Market 2023-2030 ($M) - Regional Industry Research
11.2 Pre-Filled Syringe Market 2023-2030 ($M) - Regional Industry Research
12.APAC 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-Group Market 2023-2030 ($M)
12.1 Child Market 2023-2030 ($M) - Regional Industry Research
12.2 Adult Market 2023-2030 ($M) - Regional Industry Research
12.3 Geriatrics Market 2023-2030 ($M) - Regional Industry Research
13.MENA 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type Market 2023-2030 ($M)
13.1 Single Dose Vial Market 2023-2030 ($M) - Regional Industry Research
13.2 Pre-Filled Syringe Market 2023-2030 ($M) - Regional Industry Research
14.MENA 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-Group Market 2023-2030 ($M)
14.1 Child Market 2023-2030 ($M) - Regional Industry Research
14.2 Adult Market 2023-2030 ($M) - Regional Industry Research
14.3 Geriatrics Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
2.Canada 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
3.Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
4.Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
5.Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
6.Peru 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
7.Colombia 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
8.Chile 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
9.Rest of South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
10.UK 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
11.Germany 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
12.France 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
13.Italy 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
14.Spain 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
15.Rest of Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
16.China 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
17.India 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
18.Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
19.South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
20.South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2023-2030 ($M)
21.North America 23-Valent Pneumococcal Polysaccharide Vaccine By Application
22.South America 23-Valent Pneumococcal Polysaccharide Vaccine By Application
23.Europe 23-Valent Pneumococcal Polysaccharide Vaccine By Application
24.APAC 23-Valent Pneumococcal Polysaccharide Vaccine By Application
25.MENA 23-Valent Pneumococcal Polysaccharide Vaccine By Application
26.Pfizer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Sanofi S A, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Glaxosmithkline Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Merck Co, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Astrazeneca, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Baxter International Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Beijing Minhai Biotechnology, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Serum Institute Of India, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Biogen Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Eli Lilly And Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)

Table of Contents

Report Options Request Sample Data